Bristol-Myers Squibb Company
64.41USD
-0.2800 (-0.43%)
Fetching financial statements from SEC filings…
| In $M except per-share | Q2 FY26 | Q1 FY26 | Q4 FY25* | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24* | Q3 FY24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 12,973 | 11,489 | 12,502 | 12,222 | 12,269 | 11,201 | 12,342 | 11,892 |
| Cost of Revenue | 3,726 | 3,421 | 4,097 | 3,435 | 3,372 | 3,033 | 4,812 | 2,957 |
| Gross Profit | 9,247 | 8,068 | 8,405 | 8,787 | 8,897 | 8,168 | 7,530 | 8,935 |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | 3,317 | 2,677 | 1,087 | 2,201 | 1,310 | 2,456 | 72 | 1,211 |
| EPS (Diluted) | $1.62 | $1.31 | $0.53 | $1.08 | $0.64 | $1.20 | $0.04 | $0.60 |
* Derived period (computed from FY minus reported quarters). Source: SEC filings (EDGAR)